Clinical update on the SHELTER study: A phase I/II trial of the HDAC inhibitor resminostat in patients with sorafenib-resistant hepatocellular carcinoma (HCC). A phase II study of capecitabine in ...
TUCSON, Ariz.--(BUSINESS WIRE)--Faxitron, a global leader in best-in-class digital specimen imaging systems for breast cancer intervention and life science research, today announced that the U.S. Food ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback